Antiemetic Drugs Market Analysis - Forecast(2021 - 2026)

Report Code: HCR 0141 Report Format: PDF + Excel (Delivery in 48 Hrs)

Antiemetic Drugs Market Overview

The Antiemetic Drugs Market size is forecast to reach $4.2 billion by 2025, growing at a CAGR of 6.3% during the forecast period 2020-2025. Antiemetic drugs are those that can treat conditions such as nausea and vomiting. They can be used to treat the aforementioned conditions caused by a range of illnesses. The increasing number of patients suffering from cancer and an increased number of surgeries are the major factors driving the growth of the market. High incidences of gastroenteritis and other diseases that lead to nausea and vomiting is set to further enhance the overall market demand for the Antiemetic Drugs Market during the forecast period 2020-2025.

Report Coverage

The report: “Antiemetic Drugs Market Forecast (2020-2025)”, by IndustryARC, covers an in-depth analysis of the following segments of the Antiemetic Drugs Market. 
By Type of Drugs: 5-HT3 Receptor Antagonists, Dopamine Antagonists, Steroid-Corticosteroids, Benzodiazepines, NK1 Receptor Antagonist, Antihistamines, Cannabinoids, Anticholinergic, and Others
By Applications: Chemotherapy, Pregnancy, Motion Sickness, Food Poisoning, Gastroenteritis, Dizziness, General Anesthetics, Opioid Analgesics, Emotional Stress, and Others
By Geography: North America, Europe, Asia Pacific, and Rest of the World (RoW)

Key Takeaways

  • North America dominated the Antiemetic Drugs Market in 2019 owing to the increasing incidences of cancer and the higher prevalence of the patient pool undergoing chemotherapy and the availability of the basic hospital infrastructure. The Antiemetic Drugs Market scope for different regions will be provided in the final report.
  • Increasing usage of drugs to treat the side effects of other medications including opioid analgesics, chemotherapy, and general anesthetics is likely to aid in the market growth of the Antiemetic Drugs Market.
  • Detailed analysis of the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Antiemetic Drugs Market report.
  • Lack of suitable animal model that is set to mimic the human responses to antiemetic therapy and lack of awareness about the variety of antiemetic and antinauseant drugs that are available in the market among the practitioners is set to create hurdles for the Antiemetic Drugs Market.

Type of Drugs - Segment Analysis

The Dopamine Antagonists held the largest share in the Antiemetic Drugs Market in 2019 and is estimated to grow at a CAGR of 5.1% during the forecast period 2020-2025. A dopamine antagonist (anti-dopaminergic) is a type of drug which blocks dopamine receptors by receptor antagonism. Most antipsychotics are dopamine antagonists, and as such, they have found use in treating schizophrenia, bipolar disorder, and stimulant psychosis. The dopaminergic system has been implicated in a variety of disorders. Parkinson's disease results from the loss of dopaminergic neurons in the striatum. Corticosteroids are a class of steroid hormones that are produced in the adrenal cortex of vertebrates, as well as the synthetic analogs of these hormones. Antihistamines are drugs that treat allergic rhinitis and other allergies. Histamine produces increased vascular permeability, causing fluid to escape from capillaries into tissues, which leads to the classic symptoms of an allergic reaction — a runny nose and watery eyes. Histamine also promotes angiogenesis. Benzodiazepines are set to be the highest growing segment and are estimated to register the highest CAGR during the forecast period 2020-2025 owing to its usage to treat anxiety, panic disorders, seizures, muscle tension, and insomnia.

Applications- Segment Analysis

The Chemotherapy segment held the largest share in the Antiemetic Drugs Market in 2019. Chemotherapy is a type of cancer treatment that uses one or more anti-cancer drugs as part of a standardized chemotherapy regimen. Chemotherapy is to be given with a curative intent (which almost always involves combinations of drugs), or it is aim to prolong life or to reduce symptoms (palliative chemotherapy). Traditional chemotherapeutic agents are cytotoxic using interfering with cell division (mitosis) but cancer cells vary widely in their susceptibility to these agents. To a large extent, chemotherapy can be thought of as a way to damage or stress cells, which can then lead to cell death if apoptosis is initiated. Emotional stress involves the experience of negative effects, such as anxiety, in the context of a physiological stress response that includes cardiovascular and hormonal changes. The Opioid Analgesics is set to be the highest growing segment and is estimated to register the highest CAGR during the forecast period 2020-2025.

Geography - Segment Analysis

North America dominated the Antiemetic Drugs Market in 2019 with a share of more than 41.8%, followed by the Europe owing to the increasing incidences of cancer and higher prevalence of the patient pool undergoing chemotherapy and the availability of the basic hospital infrastructure. Technological advancements and favorable government support are increasing the growth of the antiemetic drugs market in this region.

However, Europe is estimated to grow at a higher CAGR during the forecast period 2020-2025 owing to the higher adoption of the available treatments. The rapidly increasing population and increase in several diseases are also increasing the growth of the antiemetic drugs market in this region.

Drivers – Antiemetic Drugs Market  

Increasing usage of drugs to treat the side effects of other medications including opioid analgesics, chemotherapy and general anesthetics

Increasing usage of drugs to treat the side effects of other medications including opioid analgesics, chemotherapy, and general anesthetics is increasing the growth of the antiemetic drugs market. Chemotherapy is a drug treatment that uses powerful chemicals to kill fast-growing cells in the body. Chemotherapy is most often used to treat cancer since cancer cells grow and multiply much more quickly than most cells in the body. Cancer cells divide much more often than most normal cells, chemotherapy is much more likely to kill them. Some drugs kill dividing cells by damaging the part of the cell's control center that makes it divide. Other drugs interrupt the chemical processes involved in cell division. They treat many different types of cancer, such as leukemia, lymphoma, Hodgkin's disease, multiple myeloma, and sarcoma, as well as breast, lung, and ovarian cancers. Opioids have been regarded for millennia as among the most effective drugs for the treatment of pain. Their use in the management of acute severe pain and chronic pain related to advanced medical illness is considered the standard of care. Thus, increasing the growth of the antiemetic drugs market during the forecast period 2020-2025.

The Increasing number of patients suffering from cancer and increased number of surgeries

The increasing number of patients suffering from cancer and an increased number of surgeries is increasing the growth of the antiemetic drugs market. Cancer is the leading cause of the burden of disease which is measured by mortality and disability and the sixth-most expensive chronic disease, with a cancer diagnosis, treatment, and care. Cancer, also called malignancy, is an abnormal growth of cells. There are more than 100 types of cancer, including breast cancer, skin cancer, lung cancer, colon cancer, prostate cancer, and lymphoma. Symptoms vary depending on the type. Cancer treatment includes chemotherapy, radiation, and/or surgery. The number of patients suffering from cancer and the number of surgeries is increasing owing to the increased lifespan and about two-thirds of the increase is owing to longevity. Changes in alcohol consumption play an important role too. Thus, increasing the growth of the antiemetic drugs market during the forecast period 2020-2025.

Challenges – Antiemetic Drugs Market

Lack of suitable animal model that is set to mimic the human responses to antiemetic therapy and lack of awareness about the variety of antiemetic and antinauseant drugs that are available in the market among the practitioners

Some of the factors that can impede the growth of the Antiemetic Drugs Market are lack of a suitable animal model that is mimic the human responses to antiemetic therapy and lack of awareness about the variety of antiemetic and antinauseant drugs that are available in the market among the practitioners

Antiemetic Drugs Market Industry Outlook

Product launches, mergers and acquisitions, joint ventures, and R&D activities are key strategies adopted by players in the Antiemetic Drugs Market. In 2019, the Antiemetic Drugs Market share is consolidated by the top ten players present in the market. Antiemetic Drugs Market, the top 10 companies are Novartis AG, Sanofi Aventis, Abbott Laboratories, Daiichi Sankyo, Eisai Co., Ltd., GlaxoSmithKline plc, IPCA Laboratories, Merck & Co, F. Hoffmann-La Roche, and Tesaro among others.

Acquisitions/Product Launches

  • In November 2018, LGM Pharma, an API (active pharmaceutical ingredients) and procurement specialist acquired Zeta for an amount undisclosed which helped LGM Pharma to broaden its portfolio of products offering to better serve the pharmaceutical industry with a broad range of drugs and complimentary services.
1. Antiemetic Drugs Market - Overview
    1.1 Definitions and Scope
2. Antiemetic Drugs Market - Executive Summary
    2.1 Market Revenue , Market Size and Key Trends
    2.2 Key trends by Type of Drug
    2.3 Key trends by Application
    2.4 Key trends by Geography
3. Antiemetic Drugs Market – Comparative Analysis
    3.1 Product Benchmarking – Key Companies
    3.2 Financial Analysis – Key Companies
    3.3 Market Value Split by Key Companies
    3.4 Patent Analysis – Key Companies
    3.5 Pricing Analysis
4. Antiemetic Drugs Market - Startup Companies Scenario Premium
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. Antiemetic Drugs Market – Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Antiemetic Drugs Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes 
7. Antiemetic Drugs Market – Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Antiemetic Drugs Market  – By Type of Drug(Market Size –$Million/$Billion)
    8.1 5-HT3 Receptor Antagonists
    8.2 Dopamine Antagonists
    8.3 Steroid- Corticosteroids
    8.4 Benzodiazepiens
    8.5 NK1 Receptor Antagonist
    8.6 Antihistamines
    8.7 Cannabinoids
    8.8 Anticholinergic
    8.9 Others
9. Antiemetic Drugs Market  – By Applications (Market Size –$Million/$Billion)
    9.1 Chemotherapy
    9.2 Pregnancy
    9.3 Food Poisoning
    9.4 Gastroenteritis
    9.5 Diziness
    9.6 General Anesthetics
    9.7 Opiod Analgesics
    9.8 Emotional Stress
    9.9 Others
10. Antiemetic Drugs Market - By Geography (Market Size –$Million/$Billion)
    10.1 North America
        10.1.1 U.S.
        10.1.2 Mexico
        10.1.3 Canada
    10.2 Europe
        10.2.1 U.K.
        10.2.2 France
        10.2.3 Germany
        10.2.4 Italy
        10.2.5 Spain
        10.2.6 Rest of Europe
    10.3 Asia Pacific
        10.3.1 China
        10.3.2 India
        10.3.3 Japan
        10.3.4 South Korea
        10.3.5 Australia
        10.3.6 New Zealand
        10.3.7 Rest of APAC
    10.4 Rest of the World
        10.4.1 Middle East
        10.4.2 Africa
        10.4.3 South America
11. Antiemetic Drugs Market - Entropy
12. Antiemetic Drugs Market – Industry/Segment Competition Landscape Premium 
    12.1 Market Share Analysis
        12.1.1 Global Market Share – Key Companies
        12.1.2 Market Share by Region – Key companies
        12.1.3 Market Share by Countries – Key Companies
        12.1.4 Best Practices for Companies
13. Antiemetic Drugs Market – Key Company List by Country Premium Premium
14. Antiemetic Drugs Market Company Analysis
    14.1 Company 1
    14.2 Company 2
    14.3 Company 3
    14.4 Company 4
    14.5 Company 5
    14.6 Company 6
    14.7 Company 7
    14.8 Company 8
    14.9 Company 9
    14.10 Company 10
"*Financials for private companies would be provided on a best efforts basis”.
List of Tables

Table 1: Antiemetic Drugs Market Overview 2021-2026
Table 2: Antiemetic Drugs Market Leader Analysis 2018-2019 (US$)
Table 3: Antiemetic Drugs Market Product Analysis 2018-2019 (US$)
Table 4: Antiemetic Drugs Market End User Analysis 2018-2019 (US$)
Table 5: Antiemetic Drugs Market Patent Analysis 2013-2018* (US$)
Table 6: Antiemetic Drugs Market Financial Analysis 2018-2019 (US$)
Table 7: Antiemetic Drugs Market Driver Analysis 2018-2019 (US$)
Table 8: Antiemetic Drugs Market Challenges Analysis 2018-2019 (US$)
Table 9: Antiemetic Drugs Market Constraint Analysis 2018-2019 (US$)
Table 10: Antiemetic Drugs Market Supplier Bargaining Power Analysis 2018-2019 (US$)
Table 11: Antiemetic Drugs Market Buyer Bargaining Power Analysis 2018-2019 (US$)
Table 12: Antiemetic Drugs Market Threat of Substitutes Analysis 2018-2019 (US$)
Table 13: Antiemetic Drugs Market Threat of New Entrants Analysis 2018-2019 (US$)
Table 14: Antiemetic Drugs Market Degree of Competition Analysis 2018-2019 (US$)
Table 15: Antiemetic Drugs Market Value Chain Analysis 2018-2019 (US$)
Table 16: Antiemetic Drugs Market Pricing Analysis 2021-2026 (US$)
Table 17: Antiemetic Drugs Market Opportunities Analysis 2021-2026 (US$)
Table 18: Antiemetic Drugs Market Product Life Cycle Analysis 2021-2026 (US$)
Table 19: Antiemetic Drugs Market Supplier Analysis 2018-2019 (US$)
Table 20: Antiemetic Drugs Market Distributor Analysis 2018-2019 (US$)
Table 21: Antiemetic Drugs Market Trend Analysis 2018-2019 (US$)
Table 22: Antiemetic Drugs Market Size 2018 (US$)
Table 23: Antiemetic Drugs Market Forecast Analysis 2021-2026 (US$)
Table 24: Antiemetic Drugs Market Sales Forecast Analysis 2021-2026 (Units)
Table 25: Antiemetic Drugs Market, Revenue & Volume, By Type of Drug, 2021-2026 ($)
Table 26: Antiemetic Drugs Market By Type of Drug, Revenue & Volume, By 5-HT3 receptor antagonists, 2021-2026 ($)
Table 27: Antiemetic Drugs Market By Type of Drug, Revenue & Volume, By Dopamine antagonists, 2021-2026 ($)
Table 28: Antiemetic Drugs Market By Type of Drug, Revenue & Volume, By Steroid-Corticosteroids, 2021-2026 ($)
Table 29: Antiemetic Drugs Market By Type of Drug, Revenue & Volume, By Benzodiazepines, 2021-2026 ($)
Table 30: Antiemetic Drugs Market By Type of Drug, Revenue & Volume, By NK1 receptor antagonist, 2021-2026 ($)
Table 31: Antiemetic Drugs Market, Revenue & Volume, By Application, 2021-2026 ($)
Table 32: Antiemetic Drugs Market By Application, Revenue & Volume, By Chemotherapy, 2021-2026 ($)
Table 33: Antiemetic Drugs Market By Application, Revenue & Volume, By Pregnancy, 2021-2026 ($)
Table 34: Antiemetic Drugs Market By Application, Revenue & Volume, By Motion Sickness, 2021-2026 ($)
Table 35: Antiemetic Drugs Market By Application, Revenue & Volume, By Food Poisoning, 2021-2026 ($)
Table 36: Antiemetic Drugs Market By Application, Revenue & Volume, By Gastroenteritis, 2021-2026 ($)
Table 37: North America Antiemetic Drugs Market, Revenue & Volume, By Type of Drug, 2021-2026 ($)
Table 38: North America Antiemetic Drugs Market, Revenue & Volume, By Application, 2021-2026 ($)
Table 39: South america Antiemetic Drugs Market, Revenue & Volume, By Type of Drug, 2021-2026 ($)
Table 40: South america Antiemetic Drugs Market, Revenue & Volume, By Application, 2021-2026 ($)
Table 41: Europe Antiemetic Drugs Market, Revenue & Volume, By Type of Drug, 2021-2026 ($)
Table 42: Europe Antiemetic Drugs Market, Revenue & Volume, By Application, 2021-2026 ($)
Table 43: APAC Antiemetic Drugs Market, Revenue & Volume, By Type of Drug, 2021-2026 ($)
Table 44: APAC Antiemetic Drugs Market, Revenue & Volume, By Application, 2021-2026 ($)
Table 45: Middle East & Africa Antiemetic Drugs Market, Revenue & Volume, By Type of Drug, 2021-2026 ($)
Table 46: Middle East & Africa Antiemetic Drugs Market, Revenue & Volume, By Application, 2021-2026 ($)
Table 47: Russia Antiemetic Drugs Market, Revenue & Volume, By Type of Drug, 2021-2026 ($)
Table 48: Russia Antiemetic Drugs Market, Revenue & Volume, By Application, 2021-2026 ($)
Table 49: Israel Antiemetic Drugs Market, Revenue & Volume, By Type of Drug, 2021-2026 ($)
Table 50: Israel Antiemetic Drugs Market, Revenue & Volume, By Application, 2021-2026 ($)
Table 51: Top Companies 2018 (US$)Antiemetic Drugs Market, Revenue & Volume
Table 52: Product Launch 2018-2019Antiemetic Drugs Market, Revenue & Volume
Table 53: Mergers & Acquistions 2018-2019Antiemetic Drugs Market, Revenue & Volume

List of Figures

Figure 1: Overview of Antiemetic Drugs Market 2021-2026
Figure 2: Market Share Analysis for Antiemetic Drugs Market 2018 (US$)
Figure 3: Product Comparison in Antiemetic Drugs Market 2018-2019 (US$)
Figure 4: End User Profile for Antiemetic Drugs Market 2018-2019 (US$)
Figure 5: Patent Application and Grant in Antiemetic Drugs Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Antiemetic Drugs Market 2018-2019 (US$)
Figure 7: Market Entry Strategy in Antiemetic Drugs Market 2018-2019
Figure 8: Ecosystem Analysis in Antiemetic Drugs Market 2018
Figure 9: Average Selling Price in Antiemetic Drugs Market 2021-2026
Figure 10: Top Opportunites in Antiemetic Drugs Market 2018-2019
Figure 11: Market Life Cycle Analysis in Antiemetic Drugs Market
Figure 12: GlobalBy Type of DrugAntiemetic Drugs Market Revenue, 2021-2026 ($)
Figure 13: GlobalBy ApplicationAntiemetic Drugs Market Revenue, 2021-2026 ($)
Figure 14: Global Antiemetic Drugs Market - By Geography
Figure 15: Global Antiemetic Drugs Market Value & Volume, By Geography, 2021-2026 ($) 
Figure 16: Global Antiemetic Drugs Market CAGR, By Geography, 2021-2026 (%)
Figure 17: North America Antiemetic Drugs Market Value & Volume, 2021-2026 ($)
Figure 18: US Antiemetic Drugs Market Value & Volume, 2021-2026 ($)
Figure 19: US GDP and Population, 2018-2019 ($)
Figure 20: US GDP – Composition of 2018, By Sector of Origin
Figure 21: US Export and Import Value & Volume, 2018-2019 ($)
Figure 22: Canada Antiemetic Drugs Market Value & Volume, 2021-2026 ($)
Figure 23: Canada GDP and Population, 2018-2019 ($)
Figure 24: Canada GDP – Composition of 2018, By Sector of Origin
Figure 25: Canada Export and Import Value & Volume, 2018-2019 ($)
Figure 26: Mexico Antiemetic Drugs Market Value & Volume, 2021-2026 ($)
Figure 27: Mexico GDP and Population, 2018-2019 ($)
Figure 28: Mexico GDP – Composition of 2018, By Sector of Origin
Figure 29: Mexico Export and Import Value & Volume, 2018-2019 ($)
Figure 30: South America Antiemetic Drugs Market Value & Volume, 2021-2026 ($)
Figure 31: Brazil Antiemetic Drugs Market Value & Volume, 2021-2026 ($)
Figure 32: Brazil GDP and Population, 2018-2019 ($)
Figure 33: Brazil GDP – Composition of 2018, By Sector of Origin
Figure 34: Brazil Export and Import Value & Volume, 2018-2019 ($)
Figure 35: Venezuela Antiemetic Drugs Market Value & Volume, 2021-2026 ($)
Figure 36: Venezuela GDP and Population, 2018-2019 ($)
Figure 37: Venezuela GDP – Composition of 2018, By Sector of Origin
Figure 38: Venezuela Export and Import Value & Volume, 2018-2019 ($)
Figure 39: Argentina Antiemetic Drugs Market Value & Volume, 2021-2026 ($)
Figure 40: Argentina GDP and Population, 2018-2019 ($)
Figure 41: Argentina GDP – Composition of 2018, By Sector of Origin
Figure 42: Argentina Export and Import Value & Volume, 2018-2019 ($)
Figure 43: Ecuador Antiemetic Drugs Market Value & Volume, 2021-2026 ($)
Figure 44: Ecuador GDP and Population, 2018-2019 ($)
Figure 45: Ecuador GDP – Composition of 2018, By Sector of Origin
Figure 46: Ecuador Export and Import Value & Volume, 2018-2019 ($)
Figure 47: Peru Antiemetic Drugs Market Value & Volume, 2021-2026 ($)
Figure 48: Peru GDP and Population, 2018-2019 ($)
Figure 49: Peru GDP – Composition of 2018, By Sector of Origin
Figure 50: Peru Export and Import Value & Volume, 2018-2019 ($)
Figure 51: Colombia Antiemetic Drugs Market Value & Volume, 2021-2026 ($)
Figure 52: Colombia GDP and Population, 2018-2019 ($)
Figure 53: Colombia GDP – Composition of 2018, By Sector of Origin
Figure 54: Colombia Export and Import Value & Volume, 2018-2019 ($)
Figure 55: Costa Rica Antiemetic Drugs Market Value & Volume, 2021-2026 ($)
Figure 56: Costa Rica GDP and Population, 2018-2019 ($)
Figure 57: Costa Rica GDP – Composition of 2018, By Sector of Origin
Figure 58: Costa Rica Export and Import Value & Volume, 2018-2019 ($)
Figure 59: Europe Antiemetic Drugs Market Value & Volume, 2021-2026 ($)
Figure 60: U.K Antiemetic Drugs Market Value & Volume, 2021-2026 ($)
Figure 61: U.K GDP and Population, 2018-2019 ($)
Figure 62: U.K GDP – Composition of 2018, By Sector of Origin
Figure 63: U.K Export and Import Value & Volume, 2018-2019 ($)
Figure 64: Germany Antiemetic Drugs Market Value & Volume, 2021-2026 ($)
Figure 65: Germany GDP and Population, 2018-2019 ($)
Figure 66: Germany GDP – Composition of 2018, By Sector of Origin
Figure 67: Germany Export and Import Value & Volume, 2018-2019 ($)
Figure 68: Italy Antiemetic Drugs Market Value & Volume, 2021-2026 ($)
Figure 69: Italy GDP and Population, 2018-2019 ($)
Figure 70: Italy GDP – Composition of 2018, By Sector of Origin
Figure 71: Italy Export and Import Value & Volume, 2018-2019 ($)
Figure 72: France Antiemetic Drugs Market Value & Volume, 2021-2026 ($)
Figure 73: France GDP and Population, 2018-2019 ($)
Figure 74: France GDP – Composition of 2018, By Sector of Origin
Figure 75: France Export and Import Value & Volume, 2018-2019 ($)
Figure 76: Netherlands Antiemetic Drugs Market Value & Volume, 2021-2026 ($)
Figure 77: Netherlands GDP and Population, 2018-2019 ($)
Figure 78: Netherlands GDP – Composition of 2018, By Sector of Origin
Figure 79: Netherlands Export and Import Value & Volume, 2018-2019 ($)
Figure 80: Belgium Antiemetic Drugs Market Value & Volume, 2021-2026 ($)
Figure 81: Belgium GDP and Population, 2018-2019 ($)
Figure 82: Belgium GDP – Composition of 2018, By Sector of Origin
Figure 83: Belgium Export and Import Value & Volume, 2018-2019 ($)
Figure 84: Spain Antiemetic Drugs Market Value & Volume, 2021-2026 ($)
Figure 85: Spain GDP and Population, 2018-2019 ($)
Figure 86: Spain GDP – Composition of 2018, By Sector of Origin
Figure 87: Spain Export and Import Value & Volume, 2018-2019 ($)
Figure 88: Denmark Antiemetic Drugs Market Value & Volume, 2021-2026 ($)
Figure 89: Denmark GDP and Population, 2018-2019 ($)
Figure 90: Denmark GDP – Composition of 2018, By Sector of Origin
Figure 91: Denmark Export and Import Value & Volume, 2018-2019 ($)
Figure 92: APAC Antiemetic Drugs Market Value & Volume, 2021-2026 ($)
Figure 93: China Antiemetic Drugs Market Value & Volume, 2021-2026
Figure 94: China GDP and Population, 2018-2019 ($)
Figure 95: China GDP – Composition of 2018, By Sector of Origin
Figure 96: China Export and Import Value & Volume, 2018-2019 ($)Antiemetic Drugs Market China Export and Import Value & Volume, 2018-2019 ($)
Figure 97: Australia Antiemetic Drugs Market Value & Volume, 2021-2026 ($)
Figure 98: Australia GDP and Population, 2018-2019 ($)
Figure 99: Australia GDP – Composition of 2018, By Sector of Origin
Figure 100: Australia Export and Import Value & Volume, 2018-2019 ($)
Figure 101: South Korea Antiemetic Drugs Market Value & Volume, 2021-2026 ($)
Figure 102: South Korea GDP and Population, 2018-2019 ($)
Figure 103: South Korea GDP – Composition of 2018, By Sector of Origin
Figure 104: South Korea Export and Import Value & Volume, 2018-2019 ($)
Figure 105: India Antiemetic Drugs Market Value & Volume, 2021-2026 ($)
Figure 106: India GDP and Population, 2018-2019 ($)
Figure 107: India GDP – Composition of 2018, By Sector of Origin
Figure 108: India Export and Import Value & Volume, 2018-2019 ($)
Figure 109: Taiwan Antiemetic Drugs Market Value & Volume, 2021-2026 ($)
Figure 110: Taiwan GDP and Population, 2018-2019 ($)
Figure 111: Taiwan GDP – Composition of 2018, By Sector of Origin
Figure 112: Taiwan Export and Import Value & Volume, 2018-2019 ($)
Figure 113: Malaysia Antiemetic Drugs Market Value & Volume, 2021-2026 ($)
Figure 114: Malaysia GDP and Population, 2018-2019 ($)
Figure 115: Malaysia GDP – Composition of 2018, By Sector of Origin
Figure 116: Malaysia Export and Import Value & Volume, 2018-2019 ($)
Figure 117: Hong Kong Antiemetic Drugs Market Value & Volume, 2021-2026 ($)
Figure 118: Hong Kong GDP and Population, 2018-2019 ($)
Figure 119: Hong Kong GDP – Composition of 2018, By Sector of Origin
Figure 120: Hong Kong Export and Import Value & Volume, 2018-2019 ($)
Figure 121: Middle East & Africa Antiemetic Drugs Market Middle East & Africa 3D Printing Market Value & Volume, 2021-2026 ($)
Figure 122: Russia Antiemetic Drugs Market Value & Volume, 2021-2026 ($)
Figure 123: Russia GDP and Population, 2018-2019 ($)
Figure 124: Russia GDP – Composition of 2018, By Sector of Origin
Figure 125: Russia Export and Import Value & Volume, 2018-2019 ($)
Figure 126: Israel Antiemetic Drugs Market Value & Volume, 2021-2026 ($)
Figure 127: Israel GDP and Population, 2018-2019 ($)
Figure 128: Israel GDP – Composition of 2018, By Sector of Origin
Figure 129: Israel Export and Import Value & Volume, 2018-2019 ($)
Figure 130: Entropy Share, By Strategies, 2018-2019* (%)Antiemetic Drugs Market 
Figure 131: Developments, 2018-2019*Antiemetic Drugs Market 
Figure 132: Company 1 Antiemetic Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 133: Company 1 Antiemetic Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 134: Company 1 Antiemetic Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 135: Company 2 Antiemetic Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 136: Company 2 Antiemetic Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 137: Company 2 Antiemetic Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 138: Company 3 Antiemetic Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 139: Company 3 Antiemetic Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 140: Company 3 Antiemetic Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 141: Company 4 Antiemetic Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 142: Company 4 Antiemetic Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 143: Company 4 Antiemetic Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 144: Company 5 Antiemetic Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 145: Company 5 Antiemetic Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 146: Company 5 Antiemetic Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 147: Company 6 Antiemetic Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 148: Company 6 Antiemetic Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 149: Company 6 Antiemetic Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 150: Company 7 Antiemetic Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 151: Company 7 Antiemetic Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 152: Company 7 Antiemetic Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 153: Company 8 Antiemetic Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 154: Company 8 Antiemetic Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 155: Company 8 Antiemetic Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 156: Company 9 Antiemetic Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 157: Company 9 Antiemetic Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 158: Company 9 Antiemetic Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 159: Company 10 Antiemetic Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 160: Company 10 Antiemetic Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 161: Company 10 Antiemetic Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 162: Company 11 Antiemetic Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 163: Company 11 Antiemetic Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 164: Company 11 Antiemetic Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 165: Company 12 Antiemetic Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 166: Company 12 Antiemetic Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 167: Company 12 Antiemetic Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 168: Company 13 Antiemetic Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 169: Company 13 Antiemetic Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 170: Company 13 Antiemetic Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 171: Company 14 Antiemetic Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 172: Company 14 Antiemetic Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 173: Company 14 Antiemetic Drugs Market Net Sales Share, By Geography, 2018 (%)
Figure 174: Company 15 Antiemetic Drugs Market Net Revenue, By Years, 2018-2019* ($)
Figure 175: Company 15 Antiemetic Drugs Market Net Revenue Share, By Business segments, 2018 (%)
Figure 176: Company 15 Antiemetic Drugs Market Net Sales Share, By Geography, 2018 (%)